BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Latest News

US Allocates $50 Million to HP's Microfluidics Semiconductor Fab

by Roman Kasianov   •   Aug. 28, 2024  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# Manufacturing & Pharma 4.0   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

The US Department of Commerce has committed up to $50 million to HP for expanding its microfluidics semiconductor fabrication facility in Corvallis, Oregon. The funding, part of the CHIPS and Science Act, aims to enhance domestic semiconductor capabilities critical for life sciences and AI.

#advertisement
How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

HP's Corvallis fab is central to its “lab-to-fab” ecosystem, which integrates research, development, and commercial manufacturing. The investment will help HP advance its microfluidics and MEMS technologies, crucial for producing silicon devices used in drug discovery, single-cell research, and lab equipment.

The initiative is expected to generate around 150 construction jobs and over 100 manufacturing positions, with Andersen Construction leading the build. HP is also collaborating with local colleges on training programs to develop a skilled workforce for the expanded facility. The company plans to utilize the Treasury’s Investment Tax Credit, covering up to 25% of eligible capital expenses.

This move comes as global semiconductor investment heats up, with the European Semiconductor Manufacturing Company recently starting a €10 billion fab project in Dresden, Germany, backed by €5 billion in state aid under the European Chips Act. The competition underscores the race to strengthen semiconductor supply chains and innovation on both sides of the Atlantic.

 
 

Topics: Manufacturing & Pharma 4.0   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.